Want to see LUCY full AI Analyst Report?
Top Page
Innovative Eyewear, Inc.
(NASDAQ:LUCY)
Select Model
Select Model
Rating:45Neutral
Price Target:
$0.68
▲(5.08% Upside)
Action:Reiterated
Date:08/18/26
Overall score reflects weak financial fundamentals dominated by large operating losses and heavy negative free cash flow despite improving revenue and positive gross margin. Technicals add pressure with a broadly bearish trend and negative MACD. A recent $3M financing supports liquidity but introduces potential dilution, while valuation is constrained by negative earnings and no indicated dividend yield.
Positive Factors
Revenue Growth
Strong recent revenue expansion indicates improving demand and product traction. Sustained growth could help spread fixed operating costs across a larger sales base, although the company must convert this momentum into materially better profitability.
Negative Factors
Severe Operating Losses
Losses remain disproportionately large relative to revenue, showing that the current cost structure is not yet viable at existing scale. Without substantial operating leverage, cost reduction, or rapid revenue expansion, persistent deficits will continue to weaken financial sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong recent revenue expansion indicates improving demand and product traction. Sustained growth could help spread fixed operating costs across a larger sales base, although the company must convert this momentum into materially better profitability.
Read all positive factors
Innovative Eyewear, Inc. (LUCY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.03M
Dividend YieldN/A
Average Volume (3M)543.31K
Price to Earnings (P/E)―
Beta (1Y)2.48
Revenue Growth72.50%
EPS Growth58.34%
CountryUS
Employees13
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-1.35
Shares Outstanding8,609,196
10 Day Avg. Volume196,778
30 Day Avg. Volume543,314
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.44
Price to Sales (P/S)1.49
P/FCF Ratio-0.53
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.23
Revenue Forecast (FY)$7.20M
Innovative Eyewear, Inc. Business Overview & Revenue Model
Company Description
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescr...
How the Company Makes Money
Innovative Eyewear primarily makes money by selling smart eyewear products (i.e., connected/smart glasses) through wholesale and direct-to-consumer channels. Key revenue streams include: (1) product sales of smart glasses and related eyewear units...
Innovative Eyewear, Inc. Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.41M | 2.66M | 1.64M | 1.15M | 659.79K | 690.67K |
| Gross Profit | 777.54K | 567.45K | 215.19K | -119.33K | -56.29K | 148.25K |
| EBITDA | -7.60M | -7.46M | -7.62M | -6.58M | -5.54M | -3.20M |
| Net Income | -7.69M | -7.59M | -7.77M | -6.66M | -5.68M | -3.24M |
Balance Sheet | ||||||
| Total Assets | 7.47M | 10.14M | 9.84M | 6.22M | 4.69M | 824.32K |
| Cash, Cash Equivalents and Short-Term Investments | 3.74M | 6.51M | 7.52M | 4.29M | 3.59M | 79.73K |
| Total Debt | 49.40K | 0.00 | 0.00 | 0.00 | 61.36K | 289.03K |
| Total Liabilities | 574.38K | 1.07M | 743.17K | 659.94K | 665.46K | 616.80K |
| Stockholders Equity | 6.90M | 9.07M | 9.10M | 5.56M | 4.02M | 207.52K |
Cash Flow | ||||||
| Free Cash Flow | -7.39M | -7.53M | -7.01M | -6.02M | -3.44M | -1.33M |
| Operating Cash Flow | -7.20M | -7.28M | -6.74M | -5.77M | -3.22M | -1.21M |
| Investing Cash Flow | -262.15K | 4.48M | -5.16M | -198.75K | -219.95K | -118.45K |
| Financing Cash Flow | 2.29M | 6.68M | 10.24M | 6.66M | 6.96M | 1.39M |
Innovative Eyewear, Inc. Technical Analysis
Negative
0.65
Price Trends
0.82
Negative
0.92
Negative
1.12
Negative
Market Momentum
-0.03
Negative
44.62
Neutral
33.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LUCY, the sentiment is Negative. The current price of 0.65 is below the 20-day moving average (MA) of 0.71, below the 50-day MA of 0.82, and below the 200-day MA of 1.12, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 44.62 is Neutral, neither overbought nor oversold. The STOCH value of 33.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LUCY.
Innovative Eyewear, Inc. Risk Analysis
Innovative Eyewear, Inc. disclosed 40 risk factors in its most recent earnings report. Innovative Eyewear, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Innovative Eyewear, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $6.07B | -35.55 | -2.67% | ― | 8.85% | 37.70% | |
61 Neutral | $14.65B | 64.71 | 2.84% | ― | 6.09% | -42.65% | |
60 Neutral | $45.75M | -6.30 | -37.47% | ― | 64.18% | 28.90% | |
55 Neutral | $1.21B | 301.13 | 1.08% | ― | 51.30% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | $6.03M | -0.52 | -83.38% | ― | 72.50% | 58.34% |
* Healthcare Sector Average
LUCY
Innovative Eyewear, Inc.
0.71
-1.21
-62.97%
COO
Cooper Co
75.76
1.74
2.35%
STAA
Staar Surgical
24.64
-3.32
-11.87%
POCI
Precision Optics Corporation
4.34
-0.32
-6.77%
BLCO
Bausch + Lomb Corporation
17.04
2.43
16.63%
Innovative Eyewear, Inc. Corporate Events
Private Placements and Financing
Innovative Eyewear Raises $3 Million via Warrant Inducement
Positive
Jul 9, 2026
On July 8, 2026, Innovative Eyewear entered into an inducement agreement with a warrant holder to spur the cash exercise of 2,200,544 existing warrants at a reduced price of $1.35 per share, compared with the original $2.60 exercise price. In retu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.